Bumetanide Injection
Product Images NDC 31722-368

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Bumetanide (NDC 31722-368). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image
FDA Label Image

Bumetanide1mg4mlcarton (Bumetanide1mg4mlcarton)

Bumetanide1mg4mlcarton (Bumetanide1mg4mlcarton)
Packaging label for Bumetanide Injection, USP, 1 mg/4 mL (0.25 mg/mL) solution for injection. The label indicates intravenous and intramuscular routes and includes carton markings for 10 vials of 4 mL each. The labeler is Camber Pharmaceuticals, Inc., with manufacturing information for Aspiro Pharma Limited, India. Storage and dosage instructions are also partially visible on the label.*
FDA Label Image

Bumetanide1mg4mlvial (Bumetanide1mg4mlvial)

Bumetanide1mg4mlvial (Bumetanide1mg4mlvial)
Label of Bumetanide Injection, USP, 1 mg/4 mL (0.25 mg/mL) single-dose vial by Camber Pharmaceuticals, Inc. The injection is for intravenous or intramuscular use and contains benzyl alcohol. The label includes storage instructions, ingredient details, batch coding area, barcode, and manufacturer information.*
FDA Label Image

Bumetanide25mg10mlcarton (Bumetanide25mg10mlcarton)

Bumetanide25mg10mlcarton (Bumetanide25mg10mlcarton)
Packaging label for Bumetanide Injection, USP 2.5 mg/10 mL (0.25 mg/mL) by Camber Pharmaceuticals, Inc. The label states the product is for intravenous or intramuscular use and includes a quantity of 10 x 10 mL multiple-dose vials. The label provides ingredient and storage information, a barcode, and contact details for the manufacturer.*
FDA Label Image

Bumetanide25mg10mlvial (Bumetanide25mg10mlvial)

Bumetanide25mg10mlvial (Bumetanide25mg10mlvial)
Bumetanide Injection, USP 2.5 mg/10 mL (0.25 mg/mL) multiple-dose vial label. For intravenous or intramuscular use, contains benzyl alcohol as preservative. Manufactured for Camber Pharmaceuticals, Inc., Piscataway, NJ, and by Aspiro Pharma Limited, India. Includes storage instructions and ingredient details.*
FDA Label Image

Chemicalstructure (Chemicalstructure)

Chemicalstructure (Chemicalstructure)
Chemical structure of bumetanide showing its molecular formula C17H20N2O5S, including the benzene ring with attached functional groups such as carboxyl, sulfonamide, and others.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.